We are entering an important new chapter in the story of hepatitis C virus (HCV) infection.
There are clear challenges and opportunities. On the one hand, new HCV infections are still …

This article challenges the idea that cancer cannot be prevented among older adults by
examining different aspects of the relationship between age and cancer. Although the …

Importance A 2013 review for the US Preventive Services Task Force (USPSTF) of hepatitis
C virus (HCV) screening found interferon-based antiviral therapy associated with increased …

Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. A
single‐nucleotide polymorphism (SNP), rs6834314, was associated with serum liver …

Background. New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer
contraindications, increasing demand for treatment and healthcare costs. The cost …

Despite new Hepatitis C virus (HCV) therapeutic advances, challenges remain for HCV
testing and linking patients to care. A point-of-care (POC) HCV antibody testing strategy was …

Introduction Liver fibrosis and cirrhosis are late complications in Fontan palliation. Liver
biopsy is the gold standard. The goal of this study is to correlate transjugular liver biopsy …

Background The hepatitis C virus (HCV) care cascade has changed dramatically following
the introduction of direct‐acting anti‐virals (DAAs). Up‐to‐date estimates of the cascade are …

Background & Aims Cirrhosis from hepatitis C virus (HCV) infection is a major cause of end-
stage liver disease and hepatocellular carcinoma worldwide. We determine the prevalence …

Hepatitis C virus (HCV) infection, a major cause of chronic liver disease and cirrhosis, is
predominantly transmitted by exposure to blood or body fluids. The infection progresses to a …